BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan ZG, Zeng TM, Tao CJ. Current and emerging immunotherapeutic approaches for biliary tract cancers. Hepatobiliary Pancreat Dis Int 2022;21:440-9. [PMID: 36115807 DOI: 10.1016/j.hbpd.2022.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Patrone R, Ottaiano A, Nasti G, Silvestro L, Cassata A, Grassi F, Avallone A, Izzo F, Petrillo A. Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics. Infect Agent Cancer 2023;18:18. [PMID: 36927442 DOI: 10.1186/s13027-023-00495-x] [Reference Citation Analysis]
2 Granata V, Fusco R, Setola SV, Simonetti I, Picone C, Simeone E, Festino L, Vanella V, Vitale MG, Montanino A, Morabito A, Izzo F, Ascierto PA, Petrillo A. Immunotherapy Assessment: A New Paradigm for Radiologists. Diagnostics (Basel) 2023;13. [PMID: 36673112 DOI: 10.3390/diagnostics13020302] [Reference Citation Analysis]
3 Cristóbal I, Lamarca A. Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives. Cancers 2022;14:5422. [DOI: 10.3390/cancers14215422] [Reference Citation Analysis]
4 Qin LX. Immunotherapy for hepatobiliary malignancies: Progress and prospective. Hepatobiliary Pancreat Dis Int 2022;21:409-12. [PMID: 36117110 DOI: 10.1016/j.hbpd.2022.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]